2021 MIB Agents OutSmarting Osteosarcoma Grant
MIB Agents is a nationwide 501(c)(3) non-profit organization dedicated to the mission to Make It Better for children with osteosarcoma, bone cancer. The OutSmarting Osteosarcoma Grant is an annual research grant begun in 2017. Each year a grant of $100,000 is awarded to a project that will focus on moving research forward for osteosarcoma patients. Proposals may be for a new project or an ongoing larger project for which results can be expected in twelve months. The top three finalists for the OutSmarting OS 2021 grant will be required to present their proposed work via webinar with the Scientific Advisory, OutSmarting 2021 Team, and the greater osteosarcoma community.
At 12 months post-funding, results of OutSmarting grant winner’s work must be made available to share- regardless of the outcome of the research. The recipient must be available to present work underway and completed at the FACTOR 2022 Conference, and may use grant funds for travel and accommodations to FACTOR 2022 conference. PI must also provide MIB Agents with a one-page layman summary of outcomes to share with the community via the website. Grant may not be used for the formation of a new organization, used for planning stages of research, or for any indirect costs.
Eligibility & Requirements:
MIB’s Unique Proposal Process:
#TogetherWeCan and #TogetherWeWill are not just fantastic tags but a philosophy that MIB Agents work to realize. Together, as a community, we will Make It Better. Our community includes researchers, patients, doctors, families and anyone working to Make It Better for osteosarcoma patients everywhere. Therefore, the FACTOR conference and OutSmarting Osteosarcoma Grant is attended and juried by members of the entire community- scientists, physicians, patients and families. Together We Will move the understanding and treatments of osteosarcoma forward.
Specific Application Details:
The application will be submitted online through the form located on this page.
Components of application:
By attending this meeting, you can vote for the three finalists that will then be voted on by all the attendees of Virtual Finalist Meeting on February 22, 2021. The winning proposal will receive $100,000 in osteosarcoma research funding from MIB Agents.
Want to Attend? To receive an invitation to this meeting you must have donated or raised $5,000 or more for Osteosarcoma Research to MIB Agents in the year 2020. Invitations to the meeting will be sent out in December.
To make your donation today, click HERE or mail your donation to: MIB Agents, PO Box 858, Barnard VT 05031
Click the button below to learn more about our past winners
and how this funding has helped move the needle in osteosarcoma.
Congratulations to J. Andrew Livingston, MD, MS of University of Texas / MD Anderson Cancer Center